{"name":"CARRARA Diagnostic","short_name":"CARRARA Diagnostic","description":"The application, powered by AIVALS™, is designed to help brand owners, management teams, investors, and financial institutions assess the potential valuation of beauty and wellness companies with greater insight and consistency. AIVALS™ combines proprietary transaction intelligence and quantitative modelling to estimate valuation multiples for beauty and wellness companies. The model explains approximately 94% of historical transaction multiple variation and predicts observed EV/Sales multiples with an average error of approximately 0.6x, providing a robust benchmark for valuation assessment, M&A readiness and strategic planning.","icons":[{"src":"https://media.base44.com/images/public/6a17fc287cb3ae4a46b13be9/206a94713_CAlogoblueontransparent.png","sizes":"192x192","type":"image/png"},{"src":"https://media.base44.com/images/public/6a17fc287cb3ae4a46b13be9/206a94713_CAlogoblueontransparent.png","sizes":"512x512","type":"image/png"}],"start_url":"https://carrara-company-readiness.base44.app","display":"standalone","theme_color":"#000000","background_color":"#ffffff","scope":"https://carrara-company-readiness.base44.app"}